Menstural pain. Dysmenorrhoea, unspecified
Conditions
Interventions
Intervention 1: Control group: received 250 mg of mefenamic acid. Treatment was started 48h before the beginning of menstruation and continued until the 24h of bleeding until 2 cycles. Intervention 2:
Treatment - Drugs
Control group: received 250 mg of mefenamic acid. Treatment was started 48h before the beginning of menstruation and continued until the 24h of bleeding until 2 cycles.
Intervention group: received 250 mg of camomilla. Treatment was started 48h before the beginning of menstruation and continued until the 24h of bleeding until 2 cycles.
Sponsors
Kashan University of Medical Sciences
Barij Esanse company
Eligibility
Sex/Gender
Female
Age
18 Years to 29 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: 1 – having moderate or severe dysmenorrhea; 2 - not having a drug history; 3 – not having certain medical conditions; 4 – having regular cycles. Exclusion criteria: 1 - Being Married; 2 - Mild dysmenorrhea; 3 - History of a drug taking or diseases; 4 - History of taking OCP.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Dysmenorrhea. Timepoint: cycle 1 and 2 after treetment. Method of measurement: visal analogus scale. | — |
Secondary
| Measure | Time frame |
|---|---|
| Menstural pain. Timepoint: Cycles 1 and 2. Method of measurement: MQ gill pain scale. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactKarimian Zahra
Kashan University of Medical Sciences
Outcome results
None listed